GSK plc (GLAXF) is expected to report earnings on Wednesday, October 28, 2026, after the close. Consensus EPS estimate is $0.70.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | FY2026 Q2 | $0.62 | $0.67 | +8.6% | $11.15B |
| 2026-04-29 | FY2026 Q1 | $0.57 | $0.43 | -24.6% | $7.63B |
| 2025-10-28 | FY2025 Q4 | $0.63 | $0.38 | -39.8% | $6.50B |
| 2025-07-30 | FY2025 Q2 | $0.59 | $0.64 | +7.2% | $7.99B |
| 2025-04-30 | FY2025 Q1 | — | $0.58 | — | $7.52B |
| 2025-02-05 | FY2024 Q4 | $0.31 | $0.10 | -67.7% | $8.12B |
| 2024-10-30 | FY2024 Q3 | — | $-0.01 | — | $8.01B |
| 2024-07-31 | FY2024 Q2 | — | $0.29 | — | $7.88B |
GLAXF has beaten consensus EPS in 2 of its last 8 reported quarters.
See GLAXF on the live calendar →